Halpern Financial’s Bristol-Myers Squibb BMY Stock Holding History

Halpern Financial’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-100	Closed	-$6.39K	–	219
2023 Q2	$6.39K	Hold	100	–	–	﹤0.01%	200
2023 Q1	$6.93K	Sell	100 -100	-50%	-$7.05K	﹤0.01%	140
2022 Q4	$14.4K	Hold	200	–	–	0.01%	122
2022 Q3	$14.2K	Hold	200	–	–	0.01%	129
2022 Q2	$15.4K	Sell	200 -100	-33%	-$7.62K	0.01%	138
2022 Q1	$21.9K	Hold	300	–	–	0.01%	135
2021 Q4	$18.7K	Hold	300	–	–	0.01%	145
2021 Q3	$17.8K	Sell	300 -321	-52%	-$21.1K	0.01%	126
2021 Q2	$41.5K	Buy	621 +400	+181%	+$26.1K	0.02%	72
2021 Q1	$14K	Buy	+221	New	+$13.8K	0.01%	120

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Halpern Financial's BMY Position: Q3 2023 in Review

Halpern Financial sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 100 shares — an estimated $6.39K sold.

Halpern Financial first reported a position in BMY in Q1 2021 and held it in 10 quarters. The position peaked at $41.5K in Q2 2021. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Halpern Financial reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
Halpern Financial sold 100 Bristol-Myers Squibb shares in Q3 2023, an estimated $6.39K.
Halpern Financial first reported a position in Bristol-Myers Squibb in Q1 2021 and held it in 10 quarters.
Halpern Financial's Bristol-Myers Squibb position peaked at $41.5K in Q2 2021.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Halpern Financial's 13F filing for Q3 2023, filed 10 Oct 2023.